Conferences : [5705]
Collection home page

Conference papers, abstracts, posters, or presentations.

Browse
in this collection
Subscribe to this collection to receive daily e-mail notification of new additions RSS Feed RSS Feed RSS Feed
Collection's Items (Sorted by Submit Date in Descending order): 81 to 100 of 5705
< previous   next >
PreviewIssue DateTitleAuthor(s)
13-Nov-2024Pegcetacoplan for post-transplant recurrent c3 glomerulopathy (C3G) or immune complex membranoproliferative glomerulonephritis (IC-MPGN) in noble: 52-week patient evolution.Java A.; Bomback A.S.; Kavanagh D.; Remuzzi G.; Sunder-Plassmann G.; Kanellis J.; Daina E.; Walker P.D.; Wang Z.; Ahmad Z.; Fakhouri F.
13-Nov-2024Impact of Victorian Quality Indicator (QI) on kidney transplant wait-lists for Indigenous and non-Indigenous Australians.Ling R.; Davies C.E.; Mark T.-M.; McDonald S.P.; Goodman D.J.
18-Nov-2024Outcomes and challenges in percutaneous nephrolithotomy for neurogenic bladder patients.Huynh T.N.A.; Chng T.; Alex L.E.M.; Ranasinghe W.; Sewell J.
11-Nov-2024A phase 1/2 study of au-007, a monoclonal antibody (MAB) that binds to il-2 and inhibits cd25 binding, in patients with advanced solid tumors: interim results.Frentzas S. ; Ahern E.S.; Weickhardt A.J.; Haydon A.M.; De Souza P.L.; Powderly J.D.; Wyant T.; Tang J.; Richards L.; Knickerbocker A.; Amit I.; Ofran Y.; Vasselli J.R.
13-Nov-2024Circulating tumor DNA (CTDNA) as a marker of residual disease and recurrence in resected stage I-IV epithelial ovarian cancer (EOC).Ananda S.; Wang Y.; Hong W.; Richardson G.E.; Lombard J.M.; Goss G. ; Mileshkin L.R.; Steer C.B.; Lennon A.M.; McNally O.; Douville C.B.; Popoli M.; Ptak J.; Silliman N.; Dobbyn L.; Papadopoulos N.; Kinzler K.W.; Vogelstein B.; Tie J.; Gibbs P.
19-Nov-2024ASCEND: a randomised, double-blinded, phase II study of gemcitabine and nab-paclitaxel with cend-1/lsta1 or placebo in patients with untreated metastatic pancreatic ductal adenocarcinoma.Dean A.P.; Price T.J.; Sjoquist K.M.; Gebski V.; Mumford J.; Day F.; Yip S.; Bradshaw N.; Jackson C.G.C.A.; Padinharakam S.; Lee B.; Burge M.E.; Tebbutt N.C.; Steer C.B.; Lomma C.; Lam L.; Lee J. ; Chantrill L.A.; Harris M. 
19-Nov-2024Safety and clinical activity of oleclumab (o) 6 durvalumab (d) + chemotherapy (ct) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mpdac): a phase 1b/2 randomized study.Coveler A.L.; Reilley M.; Zalupski M.; Macarulla T.; Fountzilas C.; Alvarez E.C.; Nagrial A.; Uboha N.V.; Frentzas S. ; Overman M.J.; Noonan A.M.; Messersmith W.A.; Pavlakis N.; Mettu N.B.; Smith P.; Murtomaki E.; Bragulat V.; Cooper Z.A.; Kumar R.; Spigel D.
19-Nov-2024First-line lenvatinib + pembrolizumab treatment across non-clear cell renal cell carcinomas: results of the phase 2 Keynote-b61 study.Lee C.-H.; Gurney H.; Atduev V.; Suarez C.; Climent Duran M.A.; Pook D.W.; Tomczak P.; Barthelemy P.; Lee J.-L.; Nalbandian T.; Stus V.; Ferguson T.; Wiechno P.; Gokmen E.; Lacombe L.; Gedye C.; Burgents J.; Sharma M.; Peng X.; Albiges L.
11-Nov-2024A phase 1 study of the ox40 agonist, bgb-a445, with or without tislelizumab, an anti-pd-1 monoclonal antibody, in patients with advanced solid tumors.Desai J.; Davar D.; Deva S.; Gao B.; Liu T.; Matos M.; Meniawy T.; O'Byrne K.J.; Sun M.; Voskoboynik M.; Yang K.; Yu X.; Chen X.; Dong Y.; Giovinazzo H.; Leaw S.; Patel D.; Rahman T.; Wu Y.; Day D. 
16-Nov-2024Long-term clinical and psychosocial outcomes of surveillance in Li Fraumeni Syndrome.Zaheed M.; Napier C.E.; Cops E.J.; Ferris N.; Moodie K.; Milner B.; Moses D.; Poplawski N.; Dow E.G.; Harris M. ; Tucker K.; Trainer A.; James P.; Thomas D.M.; Ballinger M.L.
23-Nov-2024Semaglutide improves liver enzymes and fatty liver index in patients with obesity and cardiovascular disease - results from the SELECT trial.Meyhofer S.; Cariou B.; Cercato C.; Colhoun H.; Deanfield J.; Skalshoi Kjaer M.; Jeppesen O.; Lincoff A.M.; Lingvay I.; Newsome P.; Nicholls S. ; De Los Angeles Quiroga Pelaez M.; Santini F.; Sanyal A.; Kahn S.
23-Nov-2024Hepatocellular carcinoma and lifestyle: how do dietary patterns differ in those with metabolic and nonmetabolic dysfunction associated steatotic liver disease?Vootukuru N.; George E.; Batt N.; Sawhney R.; Bloom S.; Hodge A. ; Rodrigues B.; McCrae C.; Roberts S.; Dev A. ; Bell S. ; Sood S.; Thompson A.; Ryan M.; Kemp W.; Gow P.; Nicoll A.
23-Nov-2024Long-term follow up identifies a higher incidence of functional cure following nucleos(t)ide analogue discontinuation in hbeagnegative chronic hepatitis b.Hume S.; Hall S.; Burns G.; Tassone D.; Desmond P.; Ratnam D.; Sinclair M.; Sievert W. ; Levy M.; Sawhney R.; Nicoll A.; Valaydon Z.; Strasser S.; Ngu M.; Meredith C.; Matthews G.; Visvanathan K.; Holmes J.; Thompson A.
23-Nov-2024Initial trans-arterial chemo-embolization (TACE) is associated with similar survival outcomes as compared to upfront percutaneous ablation in those with single hepatocellular carcinoma (HCC) <= 3cm: results of a realworld propensity-matched multi-centre Australian cohort study.Abdelmalak J.; Strasser S.; Ngu N.; Dennis C.; Sinclair M.; Majumdar A.; Collins K.; Bateman K.; Dev A. ; Abasszade J.; Valaydon Z.; Saitta D.; Gazelakis K.; Byers S.; Holmes J.; Thompson A.; Pandiaraja D.; Bollipo S.; Sharma S.; Joseph M.; Nicoll A.; Sawhney R.; Riordan S.; Hannah N.; Haridy J.; Sood S.; Lam E.; Greenhill E.; Tang M.; Lubel J.; Kemp W.; Majeed A.; John Z.; Roberts S.
19-Nov-2024Immune checkpoint inhibitors and atherosclerotic cardiovascular events: a retrospective cohort study.Tan S.; Spear E.; Sane N.; Chan J.; Nelson A.J.; Nerlekar N. ; Segelov E. ; Nicholls S.J.
19-Nov-2024Longer symptom onset-to-door time persists despite reductions in stemi door-to-balloon time: insights from the Victorian Cardiac Outcomes Registry.Vasudevan S.; Dinh D.; Brennan A.; Bloom J.E.; Dawson L.P.; Nehme Z.; Lefkovits J.; Bray J.; Nicholls S.J.; Stub D.; Nelson A.J.
19-Nov-2024Women's heart clinics to prevent cardiovascular disease in women with pregnancy-related risk factors: a prospective study.Marschner S.; Mukherjee S.; Watts M.; Min H.; Beale A.L.; O'brien J.; Juneja A.; Tremmel J.; Zaman S. 
19-Nov-2024Discovery and preclinical development of ly3473329, a potent small molecule inhibitor of lipoprotein(a) formation.Michael L.; Perez C.; Lafuente C.; Sanz G.; Priego J.; Escribano A.; Calle L.; Espinosa J.; Sauder M.; Priest B.; Schultze A.; Nosie A.; Zhang H.; Nicholls S. ; Diaz N.
19-Nov-2024Understanding of seasonal influenza immunisation and its cardiovascular benefits among cardiology patients.Monagle S.R.; Spear E.; Thakur U.; Pol D.; Tan S.; Bellamy K. ; Hickman J. ; Jackson B.; Chan J.; Nicholls S.J.; Nelson A.J.
19-Nov-2024The role of seasonal influenza immunisation in cardiovascular care: a survey of cardiologists.Monagle S.R.; Spear E.; Thakur U.; Pol D.; Tan S.; Bellamy K. ; Hickman J. ; Jackson B.; Chan J.; Nicholls S.J.; Nelson A.J.
Collection's Items (Sorted by Submit Date in Descending order): 81 to 100 of 5705
< previous   next >

Date issued